Two years rituximab maintenance vs. observation after first-line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: First results of a prospect... von Rummel, Mathias J., Knauf, Wolfgang, Goerner, Martin, Soeling, Ulrike, Lange, Elisabeth, Hertenstein, Bernd, Eggert, Jochen, Schliesser, Georg C, Weide, Rudolf, Blumenstengel, Klaus, Detlefsen, Ninia, Hinke, Axel, Kauff, Frank, Barth, Juergen

Volltext